Rafael Cantón: “It is now, when there is no imminent pressure of a public health emergency such as with SARS-CoV-2, that we have to continue working to promote protocols to deal with these situatio...
Read moreEngrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the development of transformational therapies to improve the lives of patients, today announced the close o...
Read moreUn consorcio público-privado formado por la biotech Hemostatics, ubicada en el Parque Científico de Barcelona (PCB), la Clínica Universidad de Navarra (CUN) y el Institut Català d’Investigació ...
Read moreA team from Institut de Recerca Sant Joan de Déu and IRB Barcelona has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second ...
Read moreThe bacterium Mycoplasma pneumoniae, one of the smallest known microbes and a mild disease-causing human pathogen, has 43% more genes than previously thought, according to the findings of a study publ...
Read moreA study led by the Digestive Diseases and Microbiota group at the Dr. Josep Trueta Biomedical Research Institute of Girona (IDIBGI) show a potential positive impact of traditional bread on patients wi...
Read moreThe study published in the scientific journal Infection, has assessed the long-term impact of SARS-CoV-2 infection on the vascular endothelium in patients up to 12 months post-infection. Specifically,...
Read moreThere are pharmacological treatments and rehabilitation therapies available, it is important to explore complementary approaches that can improve the quality of life of these patients. Interventions b...
Read moreCientíficos del CSIC presentan nuevas tecnologías y empresas de base tecnológica en el gran evento de la innovación en España, que se celebrará en Málaga del 20 al 22 de marzo
Read moreLa donación en paro cardíaco (asistolia) ha crecido de forma continuada en los últimos años, hasta el punto de que ya ha empezado a superar la donación en muerte encefálica. En el caso del Hospi...
Read moreEsta investigación abre una nueva vía terapéutica que permitirá a otros pacientes con mutaciones en GEMIN5, que no se habían relacionado con la deficiencia de CoQ10, disponer de una terapia efect...
Read moreIQS forma parte de APATDEGRAD, un proyecto que tiene como objetivo desarrollar y validar unos nuevos apósitos para reducir la inflamación de las úlceras de pie diabético, mediante una nueva tecnol...
Read more